论文部分内容阅读
目的:观察沐舒坦在小儿支气管肺炎治疗中的临床疗效。方法:对我院2012年7月—2013年7月住院的124例支气管肺炎患儿,随机分为治疗组和对照组,两组均采用抗炎、抗病毒、止咳化痰、氧疗、雾化等对症治疗;治疗组在此基础上静脉滴注沐舒坦,观察两组的临床疗效。结果:治疗组62例中总有效57例,总有效率91.9%;对照组62例中总有效43例,总有效率69.3%,两组疗效比较,P<0.05,差异有显著性。结论:静脉滴注沐舒坦在小儿支气管肺炎中祛痰止咳效果显著,值得推广。
Objective: To observe the clinical efficacy of Mucosolvan in the treatment of pediatric bronchial pneumonia. Methods: A total of 124 children with bronchial pneumonia hospitalized from July 2012 to July 2013 in our hospital were randomly divided into treatment group and control group. The two groups were treated with anti-inflammatory, anti-virus, cough and phlegm, oxygen therapy, fog And other symptomatic treatment; treatment group on the basis of intravenous mucosolvan, observe the clinical efficacy of the two groups. Results: In the treatment group, the total effective rate was 57 in 57 cases, and the total effective rate was 91.9%. The total effective rate in the control group was 43 cases, the total effective rate was 69.3%. There was significant difference between the two groups (P <0.05). Conclusion: Mucosolvanin intravenous injection in children with bronchial pneumonia expectorant cough effect is significant, it is worth promoting.